AlloVir__2023__78_90078
Loading viewer...
investor_presentation
Format: PDF investor_presentation
This presentation by AlloVir outlines their late-stage development of allogeneic, off-the-shelf virus-specific T cell therapies, focusing on clinical progress and future strategies.
